Lee Kenneth B Jr
- SEC CIK
- 0001208570
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncDirectoras of Jun 15, 2023
- HYPD Hyperion Defi, Inc.Directoras of Jun 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lee Kenneth B Jr as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HYPD Hyperion Defi, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2022 (view filing) | May 19 | 4 days | Lee Kenneth B JrDirector | PPurchaseCommon Stock, par value $.0001 | +10.0K | $2.20 | +$22.0K | +30.9%42.3K after |
BCRX Biocryst Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Lee Kenneth B JrDirector | SSale | −6.00K | $15.35 | −$92.1K | −19.8%24.3K after |